Number of the records: 1
Immunoassays of chemically modified polysaccharides, glycans in glycoproteins and ribose in nucleic acids
- 1.
SYSNO ASEP 0476719 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title Immunoassays of chemically modified polysaccharides, glycans in glycoproteins and ribose in nucleic acids Author(s) Strmečki, S. (HR)
Trefulka, Mojmír (BFU-R) RID, ORCID
Zatloukalová, P. (CZ)
Durech, M. (CZ)
Vojtěšek, B. (CZ)
Paleček, Emil (BFU-R) RID, ORCIDNumber of authors 6 Source Title Analytica Chimica Acta. - : Elsevier - ISSN 0003-2670
Roč. 955, FEB2017 (2017), s. 108-115Number of pages 8 s. Publication form Print - P Language eng - English Country NL - Netherlands Keywords structural-characterization ; voltammetric determination ; electrochemical detection Subject RIV CB - Analytical Chemistry, Separation OECD category Analytical chemistry R&D Projects GA15-15479S GA ČR - Czech Science Foundation (CSF) Institutional support BFU-R - RVO:68081707 UT WOS 000393242700010 DOI 10.1016/j.aca.2016.12.013 Annotation Glycosylation of proteins plays an important role in health and diseases. At present new simple and inexpensive methods of glycoprotein analysis are sought. We developed a monoclonal antibody Manost 2.1 in mice after immunization with the adduct of mannan with Os(VI)temed complex (temed is N,N,N',N'-tetramethylethylenediamine). The specificity of this antibody to different biomolecules treated with Os(VI)temed was tested using dot blot immunoassay. Manost 2.1 showed specificity toward Os(VI) temed-modified polysaccharides, glycoproteins and ribonucleotide at the 3'-end in DNA. The antibody recognized neither the unmodified compounds nor the non-glycosylated proteins treated with Os(VI) temed. We also performed western blotting and Coomassie silver blue staining of mixtures of biomacromolecules treated with Os(VI)temed and identified specifically the modified glycoproteins. The immunochemical method using Manost 2.1 was compared with electrochemical analyses based on redox signals of the Os(VI)temed adducts, with similar results in terms of sensitivity. This new antibody-based approach opens the door for rapid and inexpensive analysis of glycans and glycoproteins in various scientific and medical fields, including cancer research and the future application of glycoprotein detection in clinical practice. (C) 2016 Elsevier B.V. All rights reserved. Workplace Institute of Biophysics Contact Jana Poláková, polakova@ibp.cz, Tel.: 541 517 244 Year of Publishing 2018
Number of the records: 1